Efficacy of tacrolimus 0.03% ointment as second-line treatment for children with moderate-to-severe atopic dermatitis: Evidence from a randomized, double-blind non-inferiority trial vs. fluticasone 0.005% ointment

Pediatric Allergy and Immunology

Volumn 21, Issue 2 PART 1, 2010, Pages 321-329

  Doss, N ^a   Kamoun, M R ^b   Dubertret, L ^c   Cambazard, F ^d   Remitz, A ^e   Lahfa, M ^c   De Prost, Y ^f  

^a MILITARY HOSPITAL OF TUNIS   (Tunisia)

^b CHARLES NICOLLE HOSPITAL   (Tunisia)

^c SAINT LOUIS HOSPITAL   (France)

^d HÔPITAL NORD   (France)

^e HELSINKI UNIVERSITY CENTRAL HOSPITAL   (Finland)

^f HÔPITAL NECKER ENFANTS MALADES   (France)

Author keywords

Atopic dermatitis; Children; Clinical trial; Fluticasone propionate ointment; Tacrolimus ointment

Indexed keywords

FLUTICASONE; TACROLIMUS;

ADOLESCENT; APPLICATION SITE BURNING; ARTICLE; ASTHMA; ATOPIC DERMATITIS; BRONCHITIS; CHILD; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CRANIOPHARYNGIOMA; DISEASE SEVERITY; DOUBLE BLIND PROCEDURE; DRUG EFFECT; DRUG SAFETY; EAR INFECTION; ECZEMA; FEMALE; GASTROENTERITIS; HUMAN; MAJOR CLINICAL STUDY; MALE; MULTICENTER STUDY; OUTCOME ASSESSMENT; PRESCHOOL CHILD; PRIORITY JOURNAL; PRURITUS; RANDOMIZED CONTROLLED TRIAL; RHINITIS; SCHOOL CHILD; SCORING SYSTEM; SLEEP PATTERN; TONSILLITIS; TREATMENT DURATION; TREATMENT RESPONSE;

ADOLESCENT; ANDROSTADIENES; CALCINEURIN; CHILD; CHILD, PRESCHOOL; DERMATITIS, ATOPIC; DERMATOLOGIC AGENTS; FEMALE; HUMANS; MALE; OINTMENTS; PRURITUS; RECURRENCE; SLEEP DISORDERS; TACROLIMUS; TREATMENT OUTCOME;

EID: 77950190335     PISSN: 09056157     EISSN: 13993038     Source Type: Journal    
DOI: 10.1111/j.1399-3038.2009.00895.x     Document Type: Article

References (26)

1. Kristal L, Klein PA. Atopic dermatitis in infants and children. An update. Pediatr Clin North Am 2000 : 47 : 877 895.
2. Bos JD, Kapsenberg ML, Smitt JH. Pathogenesis of atopic eczema. Lancet 1994 : 343 : 1338 1341.
3. Kapp A. The role of eosinophils in the pathogenesis of atopic dermatitis - eosinophil granule proteins as markers of disease activity. Allergy 1993 : 48 : 1 5.
4. Lubach D, Bensmann A, Bornemann U. Steroid-induced dermal atrophy. Investigations on discontinuous application. Dermatologica 1989 : 179 : 67 72.
5. Morris AD. Effects of long-term topical corticosteroids. Dermatol Pract 1998 : 5 8.
6. Anon. Topical steroid allergy and dependence. Prescrire Int 2005 : 14 : 21 2.
7. Sowden JM, Berth-Jones J, Ross JS, et al. Double-blind, controlled, crossover study of cyclosporin in adults with severe refractory atopic dermatitis. Lancet 1991 : 338 : 137 140.
8. Van Joost T, Heule F, Korstanje M, Van Den Broek MJ, Stenveld HJ, Van Vloten WA. Cyclosporin in atopic dermatitis: a multicentre placebo-controlled study. Br J Dermatol 1994 : 130 : 634 640.
9. Granlund H, Erkko P, Sinisalo M, Reitamo S. Cyclosporin in atopic dermatitis: time to relapse and effect of intermittent therapy. Br J Dermatol 1995 : 132 : 106 112.
10. Kang S, Lucky AW, Pariser D, Lawrence I, Hanifin JM. Long-term safety and efficacy of tacrolimus ointment for the treatment of atopic dermatitis in children. J Am Acad Dermatol 2001 : 44 : S58 64.
11. Paller A, Eichenfield LF, Leung DY, Stewart D, Appell M. A 12-week study of tacrolimus ointment for the treatment of atopic dermatitis in pediatric patients. J Am Acad Dermatol 2001 : 44 : S47 57.
12. Reitamo S, Van Leent EJ, Ho V, et al. Efficacy and safety of tacrolimus ointment compared with that of hydrocortisone acetate ointment in children with atopic dermatitis. J Allergy Clin Immunol 2002 : 109 : 539 546.
13. Reitamo S, Harper J, Bos JD, et al. 0.03% Tacrolimus ointment applied once or twice daily is more efficacious than 1% hydrocortisone acetate in children with moderate to severe atopic dermatitis: results of a randomized double-blind controlled trial. Br J Dermatol 2004 : 150 : 554 562.
14. Astellas Pharma GmbH. Summaries of Product Characteristics. Protopic 0.03% Ointment and Protopic 0.1% Ointment. Munich : Astellas Pharma GmbH, 2006.
15. Glaxosmithkline. FLIXOVATE® 0,05 Pour Cent Crème. FLIXOVATE® 0,05 Pour Cent Pommade. Propionate de Fluticasone. Marly-le-Roi Cedex : Laboratoire GlaxoSmithKline, 2003.
16. Rajka G, Langeland T. Grading the severity of atopic dermatitis. Acta Derm Venereol (Stockh) 1989 : 144 (Suppl. 13 4.
17. Farrington CP, Manning G. Test statistics and sample size formulae for comparative binomial trials with null hypothesis of non-zero risk difference or non-unity relative risk. Stat Med 1990 : 9 : 1447 1454.
18. Reid P, Lewis-Jones MS. Sleep difficulties and their management in preschoolers with atopic eczema. Clin Exp Dermatol 1995 : 20 : 38 41.
19. Bieber T, Vick K, Folster-Holst R, et al. Efficacy and safety of methylprednisolone aceponate ointment 0.1% compared to tacrolimus 0.03% in children and adolescents with an acute flare of severe atopic dermatitis. Allergy 2007 : 62 : 184 189.
20. Glazenburg EJ, Wolkerstorfer A, Gerretsen AL, Mulder PG, Oranje AP. Efficacy and safety of fluticasone propionate 0.005% ointment in the long-term maintenance treatment of children with atopic dermatitis: differences between boys and girls? Pediatr Allergy Immunol 2009 : 20 : 59 66.
21. Juhlin L. Comparison of fluticasone propionate cream, 0.05%, and hydrocortisone-17-butyrate cream, 0.1%, in the treatment of eczema. Cutis 1996 : 57 : 51 6.
22. Delescluse J, Van Der Endt JD. A comparison of the safety, tolerability, and efficacy of fluticasone propionate ointment, 0.005%, and betamethasone-17,21-dipropionate ointment, 0.05%, in the treatment of eczema. Cutis 1996 : 57 : 32 8.
23. Hanifin JM, Paller AS, Eichenfield L, et al. Efficacy and safety of tacrolimus ointment treatment for up to 4 years in patients with atopic dermatitis. J Am Acad Dermatol 2005 : 53 (Suppl. 2 S186 94.
24. Primary Care Dermatology Society & British Association of Dermatologists. Guidelines for the management of atopic eczema. eGuidelines 2006 : 28 : 372 375.
25. National Prescribing Centre. Atopic eczema in primary care. MeReC Bulletin 2003 : 14 : 1 4.
26. French Consensus Conference. Management of atopic dermatitis in children. Recommendations (short version). Eur J Dermatol 2005 : 15 : 215 223.